Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

HOME
Pharma Business
About us
- Media Kit
- Privacy Policy
Contact

Search for:

Tag: darolutamide

Bayer gets closer to have darolutamide as a potential treatment option for men with nmCRPC

February 27, 2019 Off

Bayer gets closer to have darolutamide as a potential treatment option for men with nmCRPC

By Dino Mustafić

darolutamide

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Attruby™ (acoramidis), a Near Complete TTR Stabilizer (≥90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients

November 23, 2024 Off

Cosentyx meets the primary endpoints

June 15, 2015 Off

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

Proudly powered by WordPress | Theme: Envo Magazine